NANO-X IMAGING LTD (NASDAQ: NNOX) Q1 2025 Earnings | May 22, 2025

2 days ago

45:25

Inside Ticker

Earnings Calls

About this video

NANO-X IMAGING LTD (NASDAQ: NNOX), an innovative medical imaging technology company, reported its Q1 2025 financial results on May 22, 2025. Revenue for the quarter reached $2.8 million, up from $2.6 million in Q1 2024, driven by growth in teleradiology services, imaging system deployments, and AI solutions. The company recorded a net loss of $13.2 million, compared to a net loss of $12.2 million in the prior-year period, reflecting higher gross loss and ongoing investments in research and commercialization. During the quarter, Nanox received 510(k) clearance from the FDA for the Nanox.ARC X, its updated multi-source digital tomosynthesis system—an important regulatory milestone. The company signed several commercial agreements to market the Nanox.ARC and Nanox.AI solutions, with over 60 units in various stages of implementation for commercial, demonstration, and clinical use worldwide. Cash equivalents and marketable securities stood at approximately $72.9 million as of March 31, 2025. CEO Erez Meltzer emphasized the company’s progress in expanding its end-to-end imaging solutions, strengthening its teleradiology business, and advancing global regulatory and commercial initiatives. Despite near-term financial challenges, Nanox continues to focus on accelerating the deployment of its technologies and building strategic partnerships to maximize market reach. Outlook: Accelerate deployment of Nanox.ARC and Nanox.AI solutions globally Continue to pursue regulatory clearances and clinical validation Expand commercial agreements and strategic partnerships Focus on operational efficiency and long-term revenue growth About Inside Ticker: For more expert analysis and real-time updates on NANO-X IMAGING LTD (NASDAQ: NNOX) and other market movers, follow Inside Ticker and visit InsideTicker.com for in-depth reports, financial insights, and the latest news on leading companies. #NanoX #NNOX #Q12025 #Earnings #MedicalImaging #Teleradiology #AI #FinancialResults #FDA #InsideTicker

Important Note: The stock market is inherently unpredictable, and forecasts are subject to change based on various factors, including economic conditions and company performance. Always consult multiple sources and consider professional advice before making investment decisions.

AI-Powered Financial Analysis This analysis uses real-time market data. While we strive for accuracy, always verify important financial information and consult with qualified financial professionals before making investment decisions. Past performance does not guarantee future results.